Table 5. ROC analysis for prediction of endpoints in patients treated with SAVR and TAVI.
1-year mortality | Combined safety endpoint at 30 days | Combined efficacy endpoint 31–365 days | Combined endpoint 0–356 days | |||||
N = 6 (14.3%) | N = 8 (19.0%) | N = 8 (19.5%) | N = 15 (35.7%) | |||||
Sig. | AUC (95% CI) | Sig. | AUC (95% CI) | Sig. | AUC (95% CI) | Sig. | AUC (95% CI) | |
EuroSCORE | 0.014* | 0.817 (0.654; 0.980) | 0.120 | 0.678 (0.491; 0.866) | 0.490 | 0.580 (0.321; 0.838) | 0.203 | 0.620 (0.440; 0.800) |
EuroSCORE II | 0.289 | 0.637 (0.423; 0.850) | 0.066 | 0.711 (0.507; 0.916) | 0.162 | 0.661 (0.485; 0.837) | 0.027* | 0.709 (0.550; 0.867) |
BNP | 0.376 | 0.614(0.343;0.885) | 0.844 | 0.523(0.332;0.714) | 0.437 | 0.590(0.353;0.827) | 0.432 | 0.574(0.394;0.755) |
NTproBNP | 0.590 | 0.569(0.327;0.812) | 0.848 | 0.522(0.327;0.717) | 0.469 | 0.583(0.366;0.800) | 0.520 | 0.560(0.380;0.741) |
Creatinine clearance | 0.719 | 0.546 (0.332; 0.761) | 0.063 | 0.713 (0.562; 0.864) | 0.717 | 0.542 (0.326; 0.757) | 0.131 | 0.642 (0.472; 0.812) |
Cystatin C | 0.685 | 0.552 (0.350; 0.755) | 0.300 | 0.619 (0.417; 0.821) | 0.839 | 0.477 (0.289; 0.664) | 0.617 | 0.547 (0.373; 0.722) |
ADMA | 0.398 | 0.609 (0.418; 0.799) | 0.923 | 0.489 (0.227; 0.751) | 0.490 | 0.580 (0.402; 0.758) | 0.969 | 0.496 (0.315; 0.678) |
Nitrite/nitrate | 0.408 | 0.394 (0.157; 0.630) | 0.195 | 0.649 (0.441; 0.857) | 0.755 | 0.536 (0.337; 0.735) | 0.394 | 0.580 (0.404; 0.757) |
8-OHdG | 0.258 | 0.646 (0.397; 0.894) | 0.019* | 0.770 (0.618; 0.923) | 0.908 | 0.513 (0.289; 0.737) | 0.128 | 0.643 (0.472; 0.814) |
FRAP | 0.337 | 0.634 (0.381; 0.887) | 0.017* | 0.809 (0.677; 0.940) | 0.243 | 0.635 (0.427; 0.843) | 0.019* | 0.731 (0.568; 0.894) |
MDA | 0.198 | 0.680 (0.462; 0.898) | 0.013* | 0.821 (0.593; 1.000) | 0.120 | 0.680 (0.500; 0.859) | 0.007* | 0.765 (0.608; 0.922) |
Cysteine | 0.135 | 0.708 (0.455; 0.962) | 0.007* | 0.809 (0.655; 0.963) | 0.887 | 0.483 (0.231; 0.734) | 0.074 | 0.672 (0.494; 0.850) |
Homocysteine | 0.392 | 0.619 (0.361; 0.878) | 0.025* | 0.758 (0.578; 0.938) | 0.915 | 0.487 (0.282; 0.692) | 0.221 | 0.618 (0.445; 0.790) |
Cysteinylglycine | 0.232 | 0.667 (0.471; 0.862) | 0.130 | 0.674 (0.439; 0.910) | 0.606 | 0.563 (0.362; 0.764) | 0.161 | 0.635 (0.452; 0.818) |
Glutathione | 0.765 | 0.458 (0.124; 0.792) | 0.308 | 0.617 (0.394; 0.841) | 0.062 | 0.727 (0.525; 0.929) | 0.660 | 0.542 (0.346; 0.738) |
TIMP1 | 0.461 | 0.595 (0.368; 0.822) | 0.003* | 0.845 (0.724; 0.965) | 0.685 | 0.547 (0.297; 0.796) | 0.058 | 0.679 (0.492; 0.867) |
MMP2 | 0.940 | 0.510 (0.311; 0.709) | 0.219 | 0.649 (0.382; 0.916) | 0.972 | 0.496 (0.288; 0.704) | 0.411 | 0.580 (0.387; 0.773) |
MMP9 | 0.101 | 0.861 (0.678; 1.000) | 0.117 | 0.726 (0.477; 0.976) | 0.637 | 0.578 (0.244; 0.912) | 0.239 | 0.657 (0.411; 0.902) |